Chemicals and Drugs

BNT162b5

A combined mRNA vaccine, developed by Pfizer and BioNTech against SARS-CoV-2 with a mixture of the original strain of SARS-CoV-2 and BA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

A combined mRNA vaccine, developed by Pfizer and BioNTech against SARS-CoV-2 with a mixture of the original strain of SARS-CoV-2 and BA.4 and BA.5 lineages of the omicron variant of SARS-CoV-2.

MeSH Record

Classification

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

MeSH Record

Synonyms

4 entry terms
  • COVID-19 Vaccine Pfizer-BioNTech, Bivalent
  • Pfizer-BioNTech COVID-19 Vaccine, Bivalent
  • COVID 19 Vaccine Pfizer BioNTech, Bivalent
  • Pfizer BioNTech COVID 19 Vaccine, Bivalent

MeSH Record

Aspects Covered

27 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, agonists, analogs & derivatives, analysis, antagonists & inhibitors, biosynthesis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.

MeSH Record

History Note

2024

MeSH Hierarchy

Tree Numbers

AMA Style

References

  1. National Library of Medicine. BNT162b5. Medical Subject Headings (MeSH). 2026. Unique ID D000096106. http://id.nlm.nih.gov/mesh/2026/D000096106
  2. BNT162b5. In: Wikidata. https://www.wikidata.org/wiki/Q124257924